RxAnte Named One of New England’s Fastest-Growing Companies by The Boston Globe

Tori-120x120

RxAnte is proud to announce our inclusion in The Boston Globe’s inaugural list of New England’s Fastest-Growing Companies. This recognition, presented in collaboration with Statista, highlights our exceptional growth and industry leadership in data science and pharmacy care management.

Between fiscal years 2020 and 2023, RxAnte experienced significant revenue growth and organic expansion, fueled in part by the successful launch of Mosaic Pharmacy Service. Introduced at the onset of the COVID-19 pandemic, Mosaic quickly became a critical solution for seniors who needed a simpler, more reliable way to manage their medications.

“Launching Mosaic as the pandemic began proved to be a pivotal moment for RxAnte,” said Josh Benner, founder and CEO. “Many seniors with chronic illnesses suddenly became shut-ins, and they needed a pharmacy service that could ensure they received the right medications—delivered directly to their homes in easy-to-use dose packaging. At the same time, the pandemic made it harder for patients to see their doctors, so Mosaic stepped in to help members get refills authorized and even find new providers when necessary. This not only accelerated Mosaic’s rapid growth but also reinforced RxAnte’s role as a trusted partner in improving medication use and health outcomes.”

RxAnte’s success is a testament to our team’s innovation and dedication to improving patient care through data-driven solutions. By integrating predictive analytics with high-touch pharmacy services, we continue to help health plans and providers deliver better, more cost-effective care.

As we look to the future, RxAnte remains focused on expanding our impact, developing cutting-edge healthcare solutions, and driving meaningful improvements in patient care.

Read more from the Boston Globe here.

Related Resources

01-13-2026

RxAnte Announces Strategic Growth Investment from Primus Capital

01-12-2026

Impact of a Pharmacy Care Management Service on Cardiometabolic Medication Adherence and Resource Use for Medicare Advantage Beneficiaries

12-15-2025

Innovative Programs and Partnerships Yield Improved Pharmacy Quality and Patient Outcomes